Patient Characteristics
| Patient . | Age/ Sex . | Diagnosis . | Duration of Disease (mo) . | Clinical Status . | Treatment . |
|---|---|---|---|---|---|
| M.E. | 55/F | MDS, RAEB | 14 | Transition into AML | CT |
| F.B. | 58/M | NHL | 21 | Rel | Cond/syn-PBSCT |
| A.R. | 52/F | CML | 4 | CP | Cond/syn-PBSCT |
| L.P. | 65/F | AML, M5 | 2 | CR | CT |
| B.G. | 30/F | BL | 2 | PR | CT |
| L.B. | 27/F | NHL | 3 | CR | Cond/syn-PBSCT |
| M.T. | 38/F | PRCA | 210 | CP | Cond/syn-PBSCT |
| C.L. | 42/M | AML, M2 | 7 | PR | Cond/allo-BMT |
| C.B. | 34/F | AML, M4 | 4 | PR | CT |
| R.M. | 45/F | ALL | 1 | CR | Cond/allo-PBSCT |
| C.H. | 38/F | CML | 2 | AP | Cond/allo-PBSCT |
| H.P. | 61/M | AML, M2 | 59 | PR | CT |
| L.J. | 62/M | AML, M2 | 5 | PR | CT |
| K.B. | 31/M | CML | 7 | PR | Cond/allo-BMT |
| M.J. | 35/F | MM | 8 | CP | Cond/allo-PBSCT |
| Y.M. | 65/F | AML, M4 | 7 | PR | CT |
| Patient . | Age/ Sex . | Diagnosis . | Duration of Disease (mo) . | Clinical Status . | Treatment . |
|---|---|---|---|---|---|
| M.E. | 55/F | MDS, RAEB | 14 | Transition into AML | CT |
| F.B. | 58/M | NHL | 21 | Rel | Cond/syn-PBSCT |
| A.R. | 52/F | CML | 4 | CP | Cond/syn-PBSCT |
| L.P. | 65/F | AML, M5 | 2 | CR | CT |
| B.G. | 30/F | BL | 2 | PR | CT |
| L.B. | 27/F | NHL | 3 | CR | Cond/syn-PBSCT |
| M.T. | 38/F | PRCA | 210 | CP | Cond/syn-PBSCT |
| C.L. | 42/M | AML, M2 | 7 | PR | Cond/allo-BMT |
| C.B. | 34/F | AML, M4 | 4 | PR | CT |
| R.M. | 45/F | ALL | 1 | CR | Cond/allo-PBSCT |
| C.H. | 38/F | CML | 2 | AP | Cond/allo-PBSCT |
| H.P. | 61/M | AML, M2 | 59 | PR | CT |
| L.J. | 62/M | AML, M2 | 5 | PR | CT |
| K.B. | 31/M | CML | 7 | PR | Cond/allo-BMT |
| M.J. | 35/F | MM | 8 | CP | Cond/allo-PBSCT |
| Y.M. | 65/F | AML, M4 | 7 | PR | CT |
Abbreviations: MDS, myelodysplastic syndrome; RAEB, refractory anemia with excess blasts; AML, acute myeloid leukemia; M2, M4, and M5, AML variants according to the French-American-British classification system; ALL, acute lymphocytic leukemia; NHL, non-Hodgkin’s lymphoma; CML, chronic myeloid leukemia; MM, multiple myeloma; BL, Burkitt’s lymphoma; PRCA, pure red blood cell aplasia; Rel, relapse; CP, chronic phase; AP, accelerated phase; CR, complete remission; PR, partial remission; CT, chemotherapy; Cond, conditioning before transplantation (high-dose CT and total body irradiation); PBSCT, peripheral blood stem cell transplantation; allo-, allogeneic; syn-, syngeneic; BMT, bone marrow transplantation.